Article Text

Download PDFPDF

O-032 Transvenous embolization of cerebrospinal fluid-venous fistulas: long-term clinical and imaging outcomes
Free
  1. D Parizadeh1,
  2. O Fermo2,
  3. K Brewer1,
  4. T Huynh1
  1. 1Radiology, Mayo Clinic, Jacksonville, FL, USA
  2. 2Neurology, Mayo Clinic, Jacksonville, FL, USA

Abstract

Introduction With promising reports of the short-term outcomes of endovascular transvenous embolization, this technique is now recognized as a highly efficient and safe treatment for patients with spontaneous intracranial hypotension (SIH) secondary to CSF-venous fistulas (CVF). Long-term efficacy beyond 3 months remains poorly described in the literature. We sought to investigate the one-year imaging and clinical outcomes of this procedure.

Methods A retrospective review of patients who underwent transvenous embolization of CSF-venous fistulas at our institution was reviewed. Patients treated between December 2020 and March 2023 were included. All patients were diagnosed with SIH based on clinical and/or imaging findings and had a definite diagnosis of CVF on lateral decubitus digital subtraction or dynamic CT myelogram. Pre-and long-term, 1-year, post-embolization clinical evaluation and brain MRI findings including the Bern SIH score were recorded and long-term post-procedural complications were reviewed.

Results During the study period, 18 patients underwent the procedure. Long-term follow-up was available for 13 patients, with median (IQR) age 61 (50 - 65) years and 62% female. Median (IQR) follow-up was 12 (10-13) months for clinical (available for 13/13 patients) and 11 (7-13) months for imaging outcomes, available for 13 and 10 patients, respectively. 10/13 (77%) patients had sustained clinical improvement, 2/13 (15%) had recurrence of symptoms due to a new leak from a new site (n = 1) or the previously embolized site (n = 1), and 1/13 (8%) did not respond to treatment. Patients also had sustained imaging improvement with a pre-embolization median (IQR) Bern SIH score of 7 (8-8) improving to 2.5 (3-4) at 3-month and 1.5 (2-3) at 1-year follow-up. There were no long-term complications. Short-term side effects were localized back pain (76%) and rebound headache (46%) which resolved in the long-term follow-up for all patients.

Conclusion Transvenous embolization has high efficacy and safety in the long-term and can be considered a durable treatment for SIH patients with CVF. A small proportion of patients may however develop new leaks which require further evaluation and treatment.

Abstract O-032 Figure 1

Imaging of a patient in their 40s diagnosed spontaneous intracranial hypotension before and after transvenous embolization of a CSF-venous fistula (CVF) at right T10. Pre-embolization sagittal T1-weighted MRI (A) shows severe midbrain sagging and low-lying cerebellar tonsils before embolization of CVF at right T10 (B) Short-term follow-up MRI at 3-months (C) and long-term follow-up MRI at 13 months (D) show sustained improvement of imaging findings which was concordant with sustained resolution of symptoms

Disclosures D. Parizadeh: None. O. Fermo: None. K. Brewer: None. T. Huynh: None.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.